Results 101 to 110 of about 37,759 (164)

Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1<sup>Glu280Ala</sup> mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial. [PDF]

open access: yesLancet Neurol
Tariot PN   +43 more
europepmc   +1 more source

Paraneoplastic dermatomyositis with atypical features associated with a solid pseudopapillary pancreatic neoplasm. [PDF]

open access: yesClin Rheumatol
Uribe-Ruíz NA   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy